Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Phillips

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Plastic and Reconstructive Surgery|March 3, 2010
Fat graft pedicle stabilization in head and neck microvascular reconstructionChady Sader, Robert Hart, Jonathan R B Trites, et al.
Plastic and Reconstructive Surgery|August 4, 2010
The communicating vein in the radial forearm free flapChady Sader, Robert D Hart, Jonathan R B Trites, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 2, 2025
Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort studyAbdallah Mughrabi, Julian Maamari, Timothy Phillips, et al.
Neurosurgical Focus|March 18, 2008
Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in ratsKarim Mukhida, Behnam A Baghbaderani, Murray Hong, et al.
Molecular Cancer Therapeutics|March 18, 2004
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanesChunhua Qin, Derek Morrow, Jessica Stewart, et al.
Cell Death & Disease|December 1, 2025
A bacterial toxin as a novel anti-cancer drug modulating the tumor-microenvironmentLingyu Li, Pauline Evain, Michael Timothy Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profileHazel J Hunt, Joseph K Belanoff, Emily Golding, et al.
Journal of Intensive Care Medicine|February 12, 2024
Association of Body Mass Index with Multiple Organ Failure in Hospitalized Patients with COVID-19: A Multicenter Retrospective Cohort StudyTimothy Phillips, Abdallah Mughrabi, Levindo J Garcia, et al.
Journal of Medicinal Chemistry|April 4, 2017
Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) AntagonistHazel J Hunt, Joseph K Belanoff, Iain Walters, et al.
Food Additives and Contaminants|July 16, 2005
Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley ratsEvans Afriyie-Gyawu, John Mackie, Bhagirathi Dash, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Plastic and Reconstructive Surgery|March 3, 2010
Fat graft pedicle stabilization in head and neck microvascular reconstructionChady Sader, Robert Hart, Jonathan R B Trites, et al.
Plastic and Reconstructive Surgery|August 4, 2010
The communicating vein in the radial forearm free flapChady Sader, Robert D Hart, Jonathan R B Trites, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 2, 2025
Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort studyAbdallah Mughrabi, Julian Maamari, Timothy Phillips, et al.
Neurosurgical Focus|March 18, 2008
Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in ratsKarim Mukhida, Behnam A Baghbaderani, Murray Hong, et al.
Molecular Cancer Therapeutics|March 18, 2004
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanesChunhua Qin, Derek Morrow, Jessica Stewart, et al.
Cell Death & Disease|December 1, 2025
A bacterial toxin as a novel anti-cancer drug modulating the tumor-microenvironmentLingyu Li, Pauline Evain, Michael Timothy Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profileHazel J Hunt, Joseph K Belanoff, Emily Golding, et al.
Journal of Intensive Care Medicine|February 12, 2024
Association of Body Mass Index with Multiple Organ Failure in Hospitalized Patients with COVID-19: A Multicenter Retrospective Cohort StudyTimothy Phillips, Abdallah Mughrabi, Levindo J Garcia, et al.
Journal of Medicinal Chemistry|April 4, 2017
Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) AntagonistHazel J Hunt, Joseph K Belanoff, Iain Walters, et al.
Food Additives and Contaminants|July 16, 2005
Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley ratsEvans Afriyie-Gyawu, John Mackie, Bhagirathi Dash, et al.
Pageof 4